Ellevest, Inc. Magenta Therapeutics, Inc. Transaction History

Ellevest, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	SELL	$0.97 - $3.08 $50 - $160	-52 Closed	0 $0
Q1 2022 Apr 19, 2022	BUY	$2.55 - $5.23 $132 - $271	52 New	52 $0
Q3 2021 Oct 19, 2021	SELL	$6.07 - $9.89 $242 - $395	-40 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$9.76 - $14.15 $214 - $311	22 Added 122.22%	40 $0
Q4 2020 Feb 04, 2021	SELL	$6.1 - $7.94 $353 - $460	-58 Reduced 76.32%	18 $0
Q3 2020 Oct 26, 2020	BUY	$6.52 - $8.94 $495 - $679	76 New	76 $1,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.